| O2 | Oxygen; |
| H2O | water; |
| ROS | Reactive Oxygen Species; |
| O2− | Superoxide anion; |
| SOD | Superoxide Dismutase; |
| H2O2 | Hydrogen Peroxide; |
| OH• | Hydroxyl Radical; |
| SOD | Superoxide Dismutase; |
| CAT | Catalase; |
| GSH-Px | Glutathione Peroxidase; |
| RGC | Retinal Ganglion Cell; |
| ER | Endoplasmic Reticulum; |
| UPR | Unfolded Protein Response; |
| Nrf2 | 2-related factor 2; |
| iNOS | Nitric Oxide Synthase inducible; |
| NF-kB | Nuclear-kB transcription Factor; |
| FDA | Food and Drug Administration; |
| RDA | Recommended Daily Allowance; |
| IOM | Institute of Medicine; |
| coQ10 | Coenzyme Q10; |
| AMD | Age-related Macular Degeneration; |
| RNS | Reactive Nitrogen Species; |
| COX-2 | Cyclooxygenase-2; |
| PGE-2 | Prostaglandin E-2; |
| IL-1 | Interleukin 1; |
| TNF-α | Tumor Necrosis Factor α; |
| PPAR-γ | Proliferator-Activated Peroxisome Receptor γ; |
| PPRE | Peroxisome Proliferator Response Element; |
| PVR | Proliferative Vitreoretinopathy; |
| PUFAs | Polynsatured Fatty Acids; |
| LA | Linoleic Acid; |
| ALA | α-Linolenic Acid; |
| EPA | Eicosapentaenoic Acid; |
| DHA | Docosahexaenoic Acid; |
| DED | Dry eye disease; |
| BPF | Bergamot polyphenolic Fraction |